Corticosteroids

Version vom 28. Juni 2020, 08:18 Uhr

32149773 ä. Effectiveness of glucocorticoid therapy in patients with severe coronavirus disease 2019: protocol of a randomized controlled trial
32272008 2020. Early preemptive immunomodulators (corticosteroids) for severe pneumonia patients infected with SARS-CoV-2
32341100 2020. Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective
32321620 ä. Corticosteroid use for 2019-nCoV infection: A double-edged sword
32283153 ä. Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-1
32389783 2020. Re: Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19.
32122468 2020. On the use of corticosteroids for 2019-nCoV pneumonia
32043983 2020. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
32372026 ä. Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis
32341331 2020. A retrospective cohort study of methylprednisolone therapy in severe patients with COVID-19 pneumonia
32133159 2020. Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia
32266987 2020. Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19)
32164084 2020. Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia
32296012 2020. Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia
C7189003 2020. Glukokortikoide und Covid-19
32475851 2020. COVID-19: Stay Cool toward Corticosteroids.
32409522 2020. Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis.
32427279 2020. Early Short Course Corticosteroids in Hospitalized Patients with COVID-19.
32474331 2020. Corticosteroids and the hyper-inflammatory phase of the COVID-19 disease.
32514902 2020. Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view.
32283144 2020. The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis.
32391369 2020. Use of Corticosteroids in Coronavirus Disease 2019 Pneumonia: A Systematic Review of the Literature.
32417314 2020. Corticosteroid use in selected patients with severe acute respiratory distress syndrome related to COVID-19.

32470160 2020. Glucocorticoid therapy delays the clearance of SARS-CoV-2 RNA in an asymptomatic COVID-19 patient.
32441786 2020. Effects of methylprednisolone use on viral genomic nucleic acid negative conversion and CT imaging lesion absorption in COVID-19 patients under 50 years old.
32034899 2020. [Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia].
32479759 2020. Successful use of methylprednisolone for treating severe COVID-19.
32496422 2020. Effects of Corticosteroid Treatment for Non-Severe COVID-19 Pneumonia: A Propensity Score-Based Analysis.